MeSH D012509 - sarcoma
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D018204:Connective and soft tissue neoplasms
0 Companies
0 Drugs
Success rate
D012509:
Sarcoma
D002296:Carcinosarcoma
0 Companies
0 Drugs
Success rate
D002813:Chondrosarcoma
0 Companies
0 Drugs
Success rate
D003557:Phyllodes tumor
0 Companies
0 Drugs
Success rate
D005354:Fibrosarcoma
D006394:Hemangiosarcoma
0 Companies
0 Drugs
Success rate
D007890:Leiomyosarcoma
D008080:Liposarcoma
D008204:Lymphangiosarcoma
0 Companies
0 Drugs
Success rate
D009217:Myosarcoma
0 Companies
0 Drugs
Success rate
D009236:Myxosarcoma
0 Companies
0 Drugs
Success rate
D012513:Experimental sarcoma
0 Companies
0 Drugs
Success rate
D012514:Kaposi sarcoma
D012516:Osteosarcoma
D013584:Synovial sarcoma
0 Companies
0 Drugs
Success rate
D018195:Adenosarcoma
0 Companies
0 Drugs
Success rate
D018199:Mesodermal mixed tumor
0 Companies
0 Drugs
Success rate
D018227:Clear cell sarcoma
0 Companies
0 Drugs
Success rate
D018228:Small cell sarcoma
0 Companies
0 Drugs
Success rate
D018234:Alveolar soft part sarcoma
0 Companies
0 Drugs
Success rate
D023981:Myeloid sarcoma
0 Companies
0 Drugs
Success rate
D036821:Endometrial stromal tumors
0 Companies
0 Drugs
Success rate
D051677:Malignant fibrous histiocytoma
0 Companies
0 Drugs
Success rate
D058405:Desmoplastic small round cell tumor
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Teva | Ifosfamide, Mesna | Ifosfamide/mesna | 2002-02-26 | |||
| Thiotepa | Thiotepa | 2001-04-20 | ||||
| Mylan | Ifosfamide | Ifosfamide | 2012-11-26 | |||
| Rising Pharmaceuticals | Mitoxantrone | Mitoxantrone | 2012-12-11 | |||
| Eli Lilly | Olaratumab | Lartruvo | 2016-10-19 | |||
| Dr Reddys Laboratories | Thiotepa | Thiotepa | 2018-05-04 | |||
| Hospira | Mitoxantrone | Mitoxantrone | 2006-04-11 | |||
| MSN Laboratories | Thiotepa | Thiotepa | 2020-03-04 | |||
| Hikma Pharmaceuticals | Ifosfamide | Ifosfamide | 2011-06-29 | |||
| Mitoxantrone | Mitoxantrone | 2006-04-11 | ||||
| Thiotepa | Thiotepa | 2023-09-05 |
1
2
3
>
Clinical Trials
Historical Success Rate
Phase 1
73%129/177
Phase 2
25%53/211
Phase 3
15%11/71
Approved: 6Overall Success rate: 3%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
>
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use